Cancer Database News Today

Patients with HPV-related oropharyngeal cancer have lower overall survival rates if they are treated at community cancer centers rather than academic centers, data suggest. Patients with HPV-related oropharyngeal cancer have lower OS rates if they are treated at community cancer centers rather than academic centers.

Patients with HPV-related oropharyngeal cancer have lower overall survival rates if they are treated at community cancer centers rather than academic centers, data suggest. Patients with HPV-related oropharyngeal cancer have lower OS rates if they are treated at community cancer centers rather than academic centers.

Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community c

Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community c

SAN CARLOS, Calif., Dec. 27, 2023 -- Iovance Biotherapeutics, Inc. , a biotechnology company focused on innovating, developing and delivering novel polyclonal tumor infiltrating lymphocyte ...

These findings suggest that addressing socioeconomic disparities and inequities that impact access to health care and services may help improve survival outcomes across racial/ethnic groups of male patients with early breast cancer.

An evaluation of data from 2018-2019 and 2020 show the effects of pandemic management on cancer screening, diagnosis, and care.

On Aug. 17, the newspaper reproduced an opinion published in the Wall Street Journal (“Another side effect of U.S. lockdowns”) that quoted results of a Lancet Oncology study (Vol. 24,

On Aug. 17, the newspaper reproduced an opinion published in the Wall Street Journal (“Another side effect of U.S. lockdowns”) that quoted results of a Lancet Oncology study (Vol. 24,

CHICAGO — Reported cases of hepatocellular carcinoma decreased significantly in 2020 compared with years before the COVID-19 pandemic, although there was minimal impact on tumor stage and patients receiving curative treatment.“Since the emergence of COVID-19, several studies have shown a substantial alteration in HCC screening and management,” Bhupinder Kaur, MD, a second-year